During the past decade, JM Research S.C conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 12 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JM Research S.C" #1 sponsor was "Pfizer" with 5 trials, followed by "Shire" with 5 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "AMAG Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JM Research S.C" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Beijing Institute of Biotechnology" with 1 trials as a collaborator, "ClinIntel" with 1 trials as a collaborator and "Clinical Reference Laboratory" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "JM Research S.C" are "COVID-19" (6 trials), "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Atopic Dermatitis" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "JM Research S.C" in a lesser frequency.

Most popular intervention types in "JM Research S.C" are "Drug" (19 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ontamalimab" (4 trials), "Baricitinib" (2 trials), "PF-07321332" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "JM Research S.C" are 22 trials for "All" genders.

Currently, there are NaN active trials in "JM Research S.C". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in JM Research S.C, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in JM Research S.C, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".